Medical technology company maxes out second capital round

SARASOTA — Omeza LLC maxed out its current funding round limit at $7 million in July, having already raised $5.75 million as of its April 1 target. 

The additional funds closed just prior to the company’s second board meeting at the company’s headquarters in Sarasota, according to a press release. 

Company founder and CEO Tom Gardner says in a statement the level of interest exceeded the agreed-upon investment limits of this round as set by the board. Total investment in Omeza through the first two rounds is now $8 million.

Omeza is a medical technology and consumer health care products company initially focused on closing chronic wounds and preventing their recurrence.